| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | histone H3K9 demethylase activity | 4.37e-06 | 14 | 47 | 3 | GO:0032454 | |
| GeneOntologyMolecularFunction | histone H3 demethylase activity | 3.84e-05 | 28 | 47 | 3 | GO:0141052 | |
| GeneOntologyMolecularFunction | histone demethylase activity | 5.25e-05 | 31 | 47 | 3 | GO:0032452 | |
| GeneOntologyMolecularFunction | histone H3K9me/H3K9me2 demethylase activity | 5.40e-05 | 5 | 47 | 2 | GO:0140683 | |
| GeneOntologyMolecularFunction | protein demethylase activity | 5.78e-05 | 32 | 47 | 3 | GO:0140457 | |
| GeneOntologyMolecularFunction | 1-phosphatidylinositol-4-phosphate 3-kinase activity | 1.13e-04 | 7 | 47 | 2 | GO:0035005 | |
| GeneOntologyMolecularFunction | 1-phosphatidylinositol-4,5-bisphosphate 3-kinase activity | 1.13e-04 | 7 | 47 | 2 | GO:0046934 | |
| GeneOntologyMolecularFunction | lipid kinase activity | 1.22e-04 | 41 | 47 | 3 | GO:0001727 | |
| GeneOntologyMolecularFunction | demethylase activity | 1.51e-04 | 44 | 47 | 3 | GO:0032451 | |
| GeneOntologyMolecularFunction | 1-phosphatidylinositol-3-kinase activity | 2.94e-04 | 11 | 47 | 2 | GO:0016303 | |
| GeneOntologyMolecularFunction | 2-oxoglutarate-dependent dioxygenase activity | 4.82e-04 | 65 | 47 | 3 | GO:0016706 | |
| GeneOntologyMolecularFunction | dioxygenase activity | 1.59e-03 | 98 | 47 | 3 | GO:0051213 | |
| GeneOntologyMolecularFunction | phosphatidylinositol kinase activity | 1.70e-03 | 26 | 47 | 2 | GO:0052742 | |
| GeneOntologyBiologicalProcess | protein depolymerization | 1.87e-05 | 144 | 47 | 5 | GO:0051261 | |
| GeneOntologyBiologicalProcess | phosphatidylinositol-mediated signaling | 2.17e-05 | 24 | 47 | 3 | GO:0048015 | |
| GeneOntologyBiologicalProcess | negative regulation of protein depolymerization | 5.01e-05 | 89 | 47 | 4 | GO:1901880 | |
| GeneOntologyBiologicalProcess | negative regulation of cytoskeleton organization | 7.78e-05 | 194 | 47 | 5 | GO:0051494 | |
| GeneOntologyBiologicalProcess | negative regulation of protein-containing complex disassembly | 7.91e-05 | 100 | 47 | 4 | GO:0043242 | |
| GeneOntologyBiologicalProcess | regulation of protein depolymerization | 9.56e-05 | 105 | 47 | 4 | GO:1901879 | |
| GeneOntologyBiologicalProcess | negative regulation of actin filament depolymerization | 2.27e-04 | 52 | 47 | 3 | GO:0030835 | |
| GeneOntologyCellularComponent | photoreceptor connecting cilium | 1.61e-04 | 48 | 46 | 3 | GO:0032391 | |
| GeneOntologyCellularComponent | phosphatidylinositol 3-kinase complex, class I | 1.69e-04 | 9 | 46 | 2 | GO:0097651 | |
| GeneOntologyCellularComponent | phosphatidylinositol 3-kinase complex, class IA | 1.69e-04 | 9 | 46 | 2 | GO:0005943 | |
| GeneOntologyCellularComponent | ciliary transition zone | 7.55e-04 | 81 | 46 | 3 | GO:0035869 | |
| MousePheno | abnormal body length | 1.56e-05 | 550 | 39 | 9 | MP:0001256 | |
| Domain | DUF3361 | 1.70e-05 | 3 | 45 | 2 | IPR024574 | |
| Domain | DUF3361 | 1.70e-05 | 3 | 45 | 2 | PF11841 | |
| Domain | PI3K_p85B | 1.70e-05 | 3 | 45 | 2 | PF02192 | |
| Domain | PI3K_p85B | 1.70e-05 | 3 | 45 | 2 | SM00143 | |
| Domain | JmjC | 2.55e-05 | 24 | 45 | 3 | PF02373 | |
| Domain | PI3K_ABD | 3.40e-05 | 4 | 45 | 2 | PS51544 | |
| Domain | PI3K_adapt-bd_dom | 3.40e-05 | 4 | 45 | 2 | IPR003113 | |
| Domain | C2_dom | 4.52e-05 | 164 | 45 | 5 | IPR000008 | |
| Domain | JMJC | 6.17e-05 | 32 | 45 | 3 | PS51184 | |
| Domain | JmjC_dom | 6.17e-05 | 32 | 45 | 3 | IPR003347 | |
| Domain | JmjC | 6.78e-05 | 33 | 45 | 3 | SM00558 | |
| Domain | ELMO | 8.46e-05 | 6 | 45 | 2 | PS51335 | |
| Domain | ELMO_CED12 | 8.46e-05 | 6 | 45 | 2 | PF04727 | |
| Domain | PH_12 | 8.46e-05 | 6 | 45 | 2 | PF16457 | |
| Domain | ELMO_dom | 8.46e-05 | 6 | 45 | 2 | IPR006816 | |
| Domain | PI3K_Ras-bd_dom | 1.18e-04 | 7 | 45 | 2 | IPR000341 | |
| Domain | PI3K_rbd | 1.18e-04 | 7 | 45 | 2 | PF00794 | |
| Domain | PI3K_RBD | 1.18e-04 | 7 | 45 | 2 | PS51546 | |
| Domain | PI3K_rbd | 1.18e-04 | 7 | 45 | 2 | SM00144 | |
| Domain | PI3K_C2_dom | 1.57e-04 | 8 | 45 | 2 | IPR002420 | |
| Domain | PI3K_C2 | 1.57e-04 | 8 | 45 | 2 | PF00792 | |
| Domain | PI3K_C2 | 1.57e-04 | 8 | 45 | 2 | PS51547 | |
| Domain | PI3K_C2 | 1.57e-04 | 8 | 45 | 2 | SM00142 | |
| Domain | PI3Ka | 2.02e-04 | 9 | 45 | 2 | PF00613 | |
| Domain | - | 2.02e-04 | 9 | 45 | 2 | 1.25.40.70 | |
| Domain | PI3Ka | 2.02e-04 | 9 | 45 | 2 | SM00145 | |
| Domain | PIK_HELICAL | 2.52e-04 | 10 | 45 | 2 | PS51545 | |
| Domain | PI_Kinase | 2.52e-04 | 10 | 45 | 2 | IPR015433 | |
| Domain | PInositide-3_kin_accessory_dom | 2.52e-04 | 10 | 45 | 2 | IPR001263 | |
| Domain | - | 4.38e-04 | 148 | 45 | 4 | 2.60.40.150 | |
| Domain | PI3/4_kinase_CS | 5.84e-04 | 15 | 45 | 2 | IPR018936 | |
| Domain | - | 6.67e-04 | 16 | 45 | 2 | 1.10.1070.11 | |
| Domain | PI3Kc | 6.67e-04 | 16 | 45 | 2 | SM00146 | |
| Domain | PI3/4_kinase_cat_dom | 8.47e-04 | 18 | 45 | 2 | IPR000403 | |
| Domain | PI3_PI4_kinase | 8.47e-04 | 18 | 45 | 2 | PF00454 | |
| Domain | PI3_4_KINASE_3 | 8.47e-04 | 18 | 45 | 2 | PS50290 | |
| Domain | PI3_4_KINASE_1 | 8.47e-04 | 18 | 45 | 2 | PS00915 | |
| Domain | PI3_4_KINASE_2 | 8.47e-04 | 18 | 45 | 2 | PS00916 | |
| Domain | PH_dom-like | 3.48e-03 | 426 | 45 | 5 | IPR011993 | |
| Domain | C2 | 4.37e-03 | 137 | 45 | 3 | SM00239 | |
| Domain | C2 | 4.83e-03 | 142 | 45 | 3 | PS50004 | |
| Domain | ARM-type_fold | 8.85e-03 | 339 | 45 | 4 | IPR016024 | |
| Pathway | REACTOME_HDMS_DEMETHYLATE_HISTONES | 4.10e-05 | 29 | 33 | 3 | MM14934 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_EBV_LMP2A_TO_PI3K_SIGNALING_PATHWAY | 5.29e-05 | 5 | 33 | 2 | M48997 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_SHIGELLA_IPGB1_TO_ITGA_B_RHOG_RAC_SIGNALING_PATHWAY | 5.29e-05 | 5 | 33 | 2 | M48982 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_SALMONELLA_SOPB_TO_RHOG_SIGNALING_PATHWAY | 5.29e-05 | 5 | 33 | 2 | M48988 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_EBV_LMP1_TO_PI3K_SIGNALING_PATHWAY | 5.29e-05 | 5 | 33 | 2 | M49020 | |
| Pathway | WP_RESISTIN_AS_A_REGULATOR_OF_INFLAMMATION | 6.08e-05 | 33 | 33 | 3 | M39745 | |
| Pathway | PID_CXCR4_PATHWAY | 8.33e-05 | 100 | 33 | 4 | M124 | |
| Pathway | REACTOME_MAPK_FAMILY_SIGNALING_CASCADES | 9.71e-05 | 327 | 33 | 6 | M27565 | |
| Pathway | WP_KISSPEPTINKISSPEPTIN_RECEPTOR_SYSTEM_IN_THE_OVARY | 1.01e-04 | 39 | 33 | 3 | M39905 | |
| Pathway | WP_NEURAL_CREST_CELL_MIGRATION_DURING_DEVELOPMENT | 1.09e-04 | 40 | 33 | 3 | M39798 | |
| Pathway | PID_ER_NONGENOMIC_PATHWAY | 1.09e-04 | 40 | 33 | 3 | M41 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ACH_CHRN_PI3K_SIGNALING_PATHWAY | 1.11e-04 | 7 | 33 | 2 | M47790 | |
| Pathway | WP_NEURAL_CREST_CELL_MIGRATION_IN_CANCER | 1.35e-04 | 43 | 33 | 3 | M39788 | |
| Pathway | PID_ERBB2_ERBB3_PATHWAY | 1.45e-04 | 44 | 33 | 3 | M175 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_PDGFR_TO_PI3K_SIGNALING_PATHWAY | 1.47e-04 | 8 | 33 | 2 | M47399 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_EGFR_TO_PI3K_SIGNALING_PATHWAY | 1.47e-04 | 8 | 33 | 2 | M47394 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_EGFR_TO_PI3K_SIGNALING_PATHWAY | 1.47e-04 | 8 | 33 | 2 | M47395 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_KIT_TO_PI3K_SIGNALING_PATHWAY | 1.47e-04 | 8 | 33 | 2 | M47404 | |
| Pathway | KEGG_MEDICUS_VARIANT_EML4_ALK_FUSION_KINASE_TO_PI3K_SIGNALING_PATHWAY | 1.47e-04 | 8 | 33 | 2 | M47405 | |
| Pathway | KEGG_MEDICUS_REFERENCE_P4_PR_PI3K_SIGNALING_PATHWAY | 1.47e-04 | 8 | 33 | 2 | M47803 | |
| Pathway | KEGG_MEDICUS_VARIANT_TGFA_OVEREXPRESSION_TO_PI3K_SIGNALING_PATHWAY | 1.47e-04 | 8 | 33 | 2 | M47482 | |
| Pathway | KEGG_MEDICUS_VARIANT_EGF_OVEREXPRESSION_TO_PI3K_SIGNALING_PATHWAY | 1.47e-04 | 8 | 33 | 2 | M47498 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_RET_TO_PI3K_SIGNALING_PATHWAY | 1.47e-04 | 8 | 33 | 2 | M47715 | |
| Pathway | WP_PHOSPHATIDYL_INOSITOL_PHOSPHATE_PATHWAY | 1.66e-04 | 46 | 33 | 3 | M48317 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_FGFR_TO_PI3K_SIGNALING_PATHWAY | 1.89e-04 | 9 | 33 | 2 | M47397 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_PI3K_SIGNALING_PATHWAY | 1.89e-04 | 9 | 33 | 2 | M47392 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_KRAS_NRAS_TO_PI3K_SIGNALING_PATHWAY | 1.89e-04 | 9 | 33 | 2 | M47391 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_MET_TO_PI3K_SIGNALING_PATHWAY | 1.89e-04 | 9 | 33 | 2 | M47402 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MEMBRANE_INITIATED_PROGESTERONE_SIGNALING_PATHWAY | 1.89e-04 | 9 | 33 | 2 | M47802 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_MET_TO_PI3K_SIGNALING_PATHWAY | 1.89e-04 | 9 | 33 | 2 | M47490 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TGFA_EGFR_PI3K_SIGNALING_PATHWAY | 1.89e-04 | 9 | 33 | 2 | M47481 | |
| Pathway | WP_PHOSPHOINOSITIDES_METABOLISM | 2.00e-04 | 49 | 33 | 3 | M40046 | |
| Pathway | REACTOME_HDMS_DEMETHYLATE_HISTONES | 2.13e-04 | 50 | 33 | 3 | M27232 | |
| Pathway | KEGG_MEDICUS_VARIANT_EGFR_OVEREXPRESSION_TO_PI3K_SIGNALING_PATHWAY | 2.36e-04 | 10 | 33 | 2 | M47400 | |
| Pathway | KEGG_MEDICUS_REFERENCE_HGF_MET_PI3K_SIGNALING_PATHWAY | 2.36e-04 | 10 | 33 | 2 | M47401 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CD80_CD86_CD28_PI3K_SIGNALING_PATHWAY | 2.36e-04 | 10 | 33 | 2 | M47615 | |
| Pathway | KEGG_INOSITOL_PHOSPHATE_METABOLISM | 2.67e-04 | 54 | 33 | 3 | M3896 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_NICOTINE_NNK_TO_PI3K_SIGNALING_PATHWAY | 2.88e-04 | 11 | 33 | 2 | M47797 | |
| Pathway | KEGG_MEDICUS_REFERENCE_KITLG_KIT_PI3K_SIGNALING_PATHWAY | 2.88e-04 | 11 | 33 | 2 | M47403 | |
| Pathway | KEGG_MEDICUS_VARIANT_BCR_ABL_FUSION_KINASE_TO_PI3K_SIGNALING_PATHWAY | 2.88e-04 | 11 | 33 | 2 | M47406 | |
| Pathway | KEGG_MEDICUS_REFERENCE_IGF2_IGF1R_PI3K_SIGNALING_PATHWAY | 2.88e-04 | 11 | 33 | 2 | M47484 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EREG_EGFR_PI3K_SIGNALING_PATHWAY | 2.88e-04 | 11 | 33 | 2 | M47499 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NRG_ERBB4_PI3K_SIGNALING_PATHWAY | 2.88e-04 | 11 | 33 | 2 | M47756 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_NNK_NNN_TO_PI3K_SIGNALING_PATHWAY_N01339 | 2.88e-04 | 11 | 33 | 2 | M47791 | |
| Pathway | KEGG_MEDICUS_REFERENCE_AREG_EGFR_PI3K_SIGNALING_PATHWAY | 2.88e-04 | 11 | 33 | 2 | M47501 | |
| Pathway | KEGG_MEDICUS_VARIANT_ERBB2_OVEREXPRESSION_TO_PI3K_SIGNALING_PATHWAY | 3.46e-04 | 12 | 33 | 2 | M47393 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_NNK_NNN_TO_PI3K_SIGNALING_PATHWAY_N01350 | 3.46e-04 | 12 | 33 | 2 | M47798 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CXCR4_GNAI_PI3K_BAD_SIGNALING_PATHWAY | 3.46e-04 | 12 | 33 | 2 | M47558 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HIV_GP120_TO_CXCR4_GNAI_PI3K_BAD_SIGNALING_PATHWAY | 3.46e-04 | 12 | 33 | 2 | M47559 | |
| Pathway | WP_RESOLVIN_E1_AND_RESOLVIN_D1_SIGNALING_DECREASE_INFLAMMATION | 3.46e-04 | 12 | 33 | 2 | M45559 | |
| Pathway | REACTOME_ERYTHROPOIETIN_ACTIVATES_PHOSPHOINOSITIDE_3_KINASE_PI3K | 3.46e-04 | 12 | 33 | 2 | M27905 | |
| Pathway | REACTOME_ERYTHROPOIETIN_ACTIVATES_PHOSPHOINOSITIDE_3_KINASE_PI3K | 3.46e-04 | 12 | 33 | 2 | MM15623 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PDGF_PDGFR_PI3K_SIGNALING_PATHWAY | 4.08e-04 | 13 | 33 | 2 | M47398 | |
| Pathway | KEGG_MEDICUS_REFERENCE_IGF_IGF1R_PI3K_SIGNALING_PATHWAY | 4.08e-04 | 13 | 33 | 2 | M47603 | |
| Pathway | REACTOME_PTK6_REGULATES_RHO_GTPASES_RAS_GTPASE_AND_MAP_KINASES | 4.08e-04 | 13 | 33 | 2 | MM15484 | |
| Pathway | REACTOME_PTK6_REGULATES_RHO_GTPASES_RAS_GTPASE_AND_MAP_KINASES | 4.75e-04 | 14 | 33 | 2 | M27734 | |
| Pathway | KEGG_MEDICUS_VARIANT_DUPLICATION_OR_MUTATION_ACTIVATED_FLT3_TO_RAS_PI3K_SIGNALING_PATHWAY | 4.75e-04 | 14 | 33 | 2 | M47390 | |
| Pathway | WP_CANCER_IMMUNOTHERAPY_BY_CTLA4_BLOCKADE | 4.75e-04 | 14 | 33 | 2 | M39840 | |
| Pathway | KEGG_MEDICUS_REFERENCE_IGF_IGFR_PI3K_NFKB_SIGNALING_PATHWAY | 4.75e-04 | 14 | 33 | 2 | M47467 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_PI3K_NFKB_SIGNALING_PATHWAY | 4.75e-04 | 14 | 33 | 2 | M47536 | |
| Pathway | WP_MODULATION_OF_PI3KAKTMTOR_SIGNALING_BY_BIOACTIVE_SPHINGOLIPIDS | 4.75e-04 | 14 | 33 | 2 | M45553 | |
| Pathway | REACTOME_SIGNALING_BY_MET | 5.06e-04 | 67 | 33 | 3 | MM15345 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_PI3K_SIGNALING_PATHWAY | 5.47e-04 | 15 | 33 | 2 | M47389 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RELN_VLDLR_PI3K_SIGNALING_PATHWAY | 5.47e-04 | 15 | 33 | 2 | M47663 | |
| Pathway | KEGG_MEDICUS_REFERENCE_FLT3LG_FLT3_RAS_PI3K_SIGNALING_PATHWAY | 5.47e-04 | 15 | 33 | 2 | M47475 | |
| Pathway | WP_CHEMOKINE_SIGNALING | 5.68e-04 | 165 | 33 | 4 | M39400 | |
| Pathway | KEGG_RENAL_CELL_CARCINOMA | 5.75e-04 | 70 | 33 | 3 | M13266 | |
| Pathway | KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY | 7.04e-04 | 75 | 33 | 3 | M5436 | |
| Pathway | REACTOME_SIGNALING_BY_ERYTHROPOIETIN | 7.07e-04 | 17 | 33 | 2 | MM15584 | |
| Pathway | SA_PTEN_PATHWAY | 7.07e-04 | 17 | 33 | 2 | M12771 | |
| Pathway | SA_TRKA_RECEPTOR | 7.07e-04 | 17 | 33 | 2 | M18895 | |
| Pathway | KEGG_VEGF_SIGNALING_PATHWAY | 7.31e-04 | 76 | 33 | 3 | M1749 | |
| Pathway | KEGG_PHOSPHATIDYLINOSITOL_SIGNALING_SYSTEM | 7.31e-04 | 76 | 33 | 3 | M9052 | |
| Pathway | REACTOME_SIGNALING_BY_MET | 8.19e-04 | 79 | 33 | 3 | M27643 | |
| Pathway | WP_CHEMOKINE_SIGNALING_PATHWAY | 8.55e-04 | 184 | 33 | 4 | MM15943 | |
| Pathway | KEGG_CHEMOKINE_SIGNALING_PATHWAY | 9.26e-04 | 188 | 33 | 4 | M4844 | |
| Pathway | WP_CANCER_PATHWAYS | 1.02e-03 | 507 | 33 | 6 | M48302 | |
| Pathway | REACTOME_REGULATION_OF_SIGNALING_BY_CBL | 1.09e-03 | 21 | 33 | 2 | MM15633 | |
| Pathway | REACTOME_REGULATION_OF_SIGNALING_BY_CBL | 1.19e-03 | 22 | 33 | 2 | M903 | |
| Pathway | REACTOME_INTERLEUKIN_RECEPTOR_SHC_SIGNALING | 1.19e-03 | 22 | 33 | 2 | MM15632 | |
| Pathway | WP_THYROID_HORMONES_PRODUCTION_AND_PERIPHERAL_DOWNSTREAM_SIGNALING_EFFECTS | 1.31e-03 | 93 | 33 | 3 | M39791 | |
| Pathway | KEGG_FC_GAMMA_R_MEDIATED_PHAGOCYTOSIS | 1.44e-03 | 96 | 33 | 3 | M16121 | |
| Pathway | WP_4HYDROXYTAMOXIFEN_DEXAMETHASONE_AND_RETINOIC_ACIDS_REGULATION_OF_P27_EXPRESSION | 1.54e-03 | 25 | 33 | 2 | M39574 | |
| Pathway | WP_RELATIONSHIP_BETWEEN_INFLAMMATION_COX2_AND_EGFR | 1.54e-03 | 25 | 33 | 2 | M39794 | |
| Pathway | WP_S1P_RECEPTOR_SIGNAL_TRANSDUCTION | 1.54e-03 | 25 | 33 | 2 | M39384 | |
| Pathway | REACTOME_SIGNALING_BY_ERYTHROPOIETIN | 1.54e-03 | 25 | 33 | 2 | M27865 | |
| Pathway | WP_MICRORNAS_IN_CARDIOMYOCYTE_HYPERTROPHY | 1.57e-03 | 99 | 33 | 3 | MM15905 | |
| Pathway | WP_IL3_SIGNALING_PATHWAY | 1.62e-03 | 100 | 33 | 3 | MM15879 | |
| Pathway | REACTOME_SIGNALING_BY_VEGF | 1.76e-03 | 103 | 33 | 3 | MM14752 | |
| Pathway | SIG_IL4RECEPTOR_IN_B_LYPHOCYTES | 1.80e-03 | 27 | 33 | 2 | M1718 | |
| Pathway | REACTOME_INTERLEUKIN_RECEPTOR_SHC_SIGNALING | 1.80e-03 | 27 | 33 | 2 | M921 | |
| Pathway | WP_MICRORNAS_IN_CARDIOMYOCYTE_HYPERTROPHY | 1.81e-03 | 104 | 33 | 3 | M39625 | |
| Pathway | REACTOME_SIGNALING_BY_VEGF | 1.91e-03 | 106 | 33 | 3 | M27077 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ITGA_B_RHOG_RAC_SIGNALING_PATHWAY | 1.93e-03 | 28 | 33 | 2 | M47655 | |
| Pathway | PID_TRAIL_PATHWAY | 1.93e-03 | 28 | 33 | 2 | M79 | |
| Pathway | WP_THERMOGENESIS | 2.02e-03 | 108 | 33 | 3 | M39746 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PRNP_PI3K_NOX2_SIGNALING_PATHWAY | 2.07e-03 | 29 | 33 | 2 | M47764 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_SHIGELLA_IPGD_TO_ARNO_ARF_ACTB_G_SIGNALING_PATHWAY | 2.07e-03 | 29 | 33 | 2 | M47717 | |
| Pathway | WP_GLYCEROPHOSPHOLIPID_BIOSYNTHETIC_PATHWAY | 2.22e-03 | 30 | 33 | 2 | M39592 | |
| Pathway | PID_EPHRINB_REV_PATHWAY | 2.22e-03 | 30 | 33 | 2 | M257 | |
| Pubmed | 3.79e-07 | 11 | 47 | 3 | 23077641 | ||
| Pubmed | PI3 kinase alpha and delta promote hematopoietic stem cell activation. | 1.79e-06 | 2 | 47 | 2 | 31120863 | |
| Pubmed | Inhibition of the p110α isoform of PI 3-kinase stimulates nonfunctional tumor angiogenesis. | 1.79e-06 | 2 | 47 | 2 | 24043760 | |
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 28692045 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 26883061 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 23341541 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 21188463 | ||
| Pubmed | PI3-kinase deletion promotes myelodysplasia by dysregulating autophagy in hematopoietic stem cells. | 5.36e-06 | 3 | 47 | 2 | 36812307 | |
| Pubmed | Differential distribution of ELMO1 and ELMO2 mRNAs in the developing mouse brain. | 5.36e-06 | 3 | 47 | 2 | 16443196 | |
| Pubmed | 5.36e-06 | 3 | 47 | 2 | 34023498 | ||
| Pubmed | Isoform-specific phosphoinositide 3-kinase inhibitors exert distinct effects in solid tumors. | 5.36e-06 | 3 | 47 | 2 | 20103642 | |
| Pubmed | Essential role for the p110delta phosphoinositide 3-kinase in the allergic response. | 5.36e-06 | 3 | 47 | 2 | 15496927 | |
| Pubmed | IQCJ-SCHIP1, a novel fusion transcript encoding a calmodulin-binding IQ motif protein. | 5.36e-06 | 3 | 47 | 2 | 17045569 | |
| Pubmed | 5.36e-06 | 3 | 47 | 2 | 18984585 | ||
| Pubmed | 5.36e-06 | 3 | 47 | 2 | 28339079 | ||
| Pubmed | 5.36e-06 | 3 | 47 | 2 | 27176780 | ||
| Pubmed | 5.36e-06 | 3 | 47 | 2 | 28515318 | ||
| Pubmed | Class IA PI3Ks regulate subcellular and functional dynamics of IDO1. | 5.36e-06 | 3 | 47 | 2 | 33159421 | |
| Pubmed | 5.36e-06 | 3 | 47 | 2 | 24553178 | ||
| Pubmed | 5.36e-06 | 3 | 47 | 2 | 31831213 | ||
| Pubmed | 1.07e-05 | 4 | 47 | 2 | 29526734 | ||
| Pubmed | 1.07e-05 | 4 | 47 | 2 | 23593242 | ||
| Pubmed | PI 3-kinase p110beta: a new target for antithrombotic therapy. | 1.07e-05 | 4 | 47 | 2 | 15834429 | |
| Pubmed | 1.07e-05 | 4 | 47 | 2 | 9235916 | ||
| Pubmed | Distinct roles of class IA PI3K isoforms in primary and immortalised macrophages. | 1.07e-05 | 4 | 47 | 2 | 19033389 | |
| Pubmed | Activity of any class IA PI3K isoform can sustain cell proliferation and survival. | 1.07e-05 | 4 | 47 | 2 | 20534549 | |
| Pubmed | 1.07e-05 | 4 | 47 | 2 | 16603237 | ||
| Pubmed | 1.07e-05 | 4 | 47 | 2 | 11595183 | ||
| Pubmed | G-protein coupled receptor BAI3 promotes myoblast fusion in vertebrates. | 1.07e-05 | 4 | 47 | 2 | 24567399 | |
| Pubmed | 1.07e-05 | 4 | 47 | 2 | 27979964 | ||
| Pubmed | Loss of Phosphatidylinositol 3-Kinase Activity in Regulatory T Cells Leads to Neuronal Inflammation. | 1.07e-05 | 4 | 47 | 2 | 32414808 | |
| Pubmed | 1.07e-05 | 4 | 47 | 2 | 23029326 | ||
| Pubmed | 1.07e-05 | 4 | 47 | 2 | 17920279 | ||
| Pubmed | 1.07e-05 | 4 | 47 | 2 | 20699475 | ||
| Pubmed | 1.07e-05 | 4 | 47 | 2 | 18713068 | ||
| Pubmed | 1.07e-05 | 4 | 47 | 2 | 23023391 | ||
| Pubmed | 1.78e-05 | 5 | 47 | 2 | 25950943 | ||
| Pubmed | 1.78e-05 | 5 | 47 | 2 | 26442967 | ||
| Pubmed | 1.78e-05 | 5 | 47 | 2 | 18550753 | ||
| Pubmed | Identification of a novel protein interaction between Elmo1 and Cdc27. | 1.78e-05 | 5 | 47 | 2 | 26882976 | |
| Pubmed | 1.78e-05 | 5 | 47 | 2 | 22084313 | ||
| Pubmed | 1.78e-05 | 5 | 47 | 2 | 28178653 | ||
| Pubmed | TRPM7 ion channels are required for sustained phosphoinositide 3-kinase signaling in lymphocytes. | 1.78e-05 | 5 | 47 | 2 | 18590694 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | 1.83e-05 | 861 | 47 | 8 | 36931259 | |
| Pubmed | Site-specific serine phosphorylation of the IL-3 receptor is required for hemopoietic cell survival. | 2.67e-05 | 6 | 47 | 2 | 10949031 | |
| Pubmed | Identification and characterization of JMJD2 family genes in silico. | 2.67e-05 | 6 | 47 | 2 | 15138608 | |
| Pubmed | 2.67e-05 | 6 | 47 | 2 | 23588386 | ||
| Pubmed | 2.67e-05 | 6 | 47 | 2 | 15213298 | ||
| Pubmed | Autophagy regulates IL-23 secretion and innate T cell responses through effects on IL-1 secretion. | 2.67e-05 | 6 | 47 | 2 | 22972933 | |
| Pubmed | Tensin 3 is a new partner of Dock5 that controls osteoclast podosome organization and activity. | 2.67e-05 | 6 | 47 | 2 | 27505886 | |
| Pubmed | The emerging mechanisms of isoform-specific PI3K signalling. | 2.67e-05 | 6 | 47 | 2 | 20379207 | |
| Pubmed | 2.67e-05 | 6 | 47 | 2 | 26730736 | ||
| Pubmed | 2.67e-05 | 6 | 47 | 2 | 32679061 | ||
| Pubmed | Mouse models of human ocular disease for translational research. | 2.67e-05 | 6 | 47 | 2 | 28859131 | |
| Pubmed | Critical role for the p110alpha phosphoinositide-3-OH kinase in growth and metabolic regulation. | 2.67e-05 | 6 | 47 | 2 | 16625210 | |
| Pubmed | 2.95e-05 | 44 | 47 | 3 | 24183668 | ||
| Pubmed | 3.74e-05 | 7 | 47 | 2 | 31521773 | ||
| Pubmed | 3.74e-05 | 7 | 47 | 2 | 28262558 | ||
| Pubmed | 4.08e-05 | 49 | 47 | 3 | 34368113 | ||
| Pubmed | 4.88e-05 | 52 | 47 | 3 | 23182705 | ||
| Pubmed | Control of axonal growth and regeneration of sensory neurons by the p110delta PI 3-kinase. | 4.98e-05 | 8 | 47 | 2 | 17846664 | |
| Pubmed | 4.98e-05 | 8 | 47 | 2 | 21540297 | ||
| Pubmed | RAS and RHO families of GTPases directly regulate distinct phosphoinositide 3-kinase isoforms. | 4.98e-05 | 8 | 47 | 2 | 23706742 | |
| Pubmed | 5.17e-05 | 53 | 47 | 3 | 36265442 | ||
| Pubmed | 6.26e-05 | 750 | 47 | 7 | 11230166 | ||
| Pubmed | 6.40e-05 | 9 | 47 | 2 | 18367611 | ||
| Pubmed | 6.40e-05 | 9 | 47 | 2 | 21765914 | ||
| Pubmed | 6.43e-05 | 57 | 47 | 3 | 18022353 | ||
| Pubmed | 6.92e-05 | 162 | 47 | 4 | 15174051 | ||
| Pubmed | 7.99e-05 | 10 | 47 | 2 | 9113989 | ||
| Pubmed | The HIV-1 nef protein interferes with phosphatidylinositol 3-kinase activation 1. | 7.99e-05 | 10 | 47 | 2 | 8636073 | |
| Pubmed | RhoG activates Rac1 by direct interaction with the Dock180-binding protein Elmo. | 7.99e-05 | 10 | 47 | 2 | 12879077 | |
| Pubmed | 7.99e-05 | 10 | 47 | 2 | 8798481 | ||
| Pubmed | Expression of HIV-1 nef decreases basal phosphatidyl-inositol 3-kinase activity. | 7.99e-05 | 10 | 47 | 2 | 9247029 | |
| Pubmed | 9.33e-05 | 549 | 47 | 6 | 38280479 | ||
| Pubmed | 9.75e-05 | 11 | 47 | 2 | 18449193 | ||
| Pubmed | 9.75e-05 | 11 | 47 | 2 | 9927325 | ||
| Pubmed | 9.75e-05 | 11 | 47 | 2 | 16081599 | ||
| Pubmed | 9.75e-05 | 11 | 47 | 2 | 9708406 | ||
| Pubmed | 9.75e-05 | 11 | 47 | 2 | 10985305 | ||
| Pubmed | Nef-mediated disruption of HLA-A2 transport to the cell surface in T cells. | 9.75e-05 | 11 | 47 | 2 | 12584329 | |
| Pubmed | 9.75e-05 | 11 | 47 | 2 | 9808187 | ||
| Pubmed | 9.75e-05 | 11 | 47 | 2 | 25104021 | ||
| Pubmed | 1.17e-04 | 12 | 47 | 2 | 14602571 | ||
| Pubmed | 1.17e-04 | 12 | 47 | 2 | 16514418 | ||
| Pubmed | 1.17e-04 | 12 | 47 | 2 | 36400788 | ||
| Pubmed | 1.17e-04 | 12 | 47 | 2 | 10208934 | ||
| Pubmed | 1.17e-04 | 12 | 47 | 2 | 12077252 | ||
| Pubmed | 1.17e-04 | 12 | 47 | 2 | 9341793 | ||
| Pubmed | 1.17e-04 | 12 | 47 | 2 | 12551992 | ||
| Pubmed | 1.38e-04 | 13 | 47 | 2 | 23215766 | ||
| Pubmed | 1.38e-04 | 13 | 47 | 2 | 21930703 | ||
| Pubmed | 1.38e-04 | 13 | 47 | 2 | 9394803 | ||
| Pubmed | 1.61e-04 | 14 | 47 | 2 | 26075907 | ||
| Pubmed | 1.61e-04 | 14 | 47 | 2 | 17157319 | ||
| Pubmed | 1.61e-04 | 14 | 47 | 2 | 26270987 | ||
| Pubmed | Chemokine coreceptor signaling in HIV-1 infection and pathogenesis. | 1.61e-04 | 14 | 47 | 2 | 20041213 | |
| Pubmed | 1.65e-04 | 203 | 47 | 4 | 19953087 | ||
| Pubmed | HIV Nef enhances Tat-mediated viral transcription through a hnRNP-K-nucleated signaling complex. | 1.86e-04 | 15 | 47 | 2 | 18854243 | |
| Pubmed | 1.86e-04 | 15 | 47 | 2 | 20702582 | ||
| Cytoband | 7p14.1 | 3.28e-04 | 26 | 47 | 2 | 7p14.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr3q25 | 8.47e-04 | 180 | 47 | 3 | chr3q25 | |
| GeneFamily | Engulfment and cell motility proteins | 9.68e-06 | 3 | 33 | 2 | 543 | |
| GeneFamily | PHD finger proteins|Lysine demethylases | 1.09e-05 | 24 | 33 | 3 | 485 | |
| GeneFamily | Phosphatidylinositol 3-kinase subunits | 8.98e-05 | 8 | 33 | 2 | 831 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 3.11e-03 | 161 | 33 | 3 | 593 | |
| ToppCell | PBMC-Mild-Hematopoietic-HSPC|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.78e-05 | 179 | 47 | 4 | 2f690f933bf6b99abeb31766e0b22bdbe36c1ba0 | |
| ToppCell | COVID-19_Mild-Hematopoietic_SC-HSPC|COVID-19_Mild / Disease group, lineage and cell class | 3.78e-05 | 179 | 47 | 4 | 19fcf48f5e02e4cb2b328efb4502f337e1282f72 | |
| ToppCell | PBMC-Mild-Hematopoietic-HSPC-HSPC-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.78e-05 | 179 | 47 | 4 | 4bb2debfc9e9f258cd38e797ef160bd440aad6af | |
| ToppCell | PBMC-Mild-Hematopoietic-HSPC-HSPC|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.78e-05 | 179 | 47 | 4 | 3e2c937369b8190fd5d5a31689d029e6e89fb5e2 | |
| ToppCell | COVID-19_Mild-Hematopoietic_SC|COVID-19_Mild / Disease group, lineage and cell class | 3.78e-05 | 179 | 47 | 4 | 50a073166e34bcfa52a62c4dafb3aef724e0fa8e | |
| ToppCell | PBMC-Mild-Hematopoietic-HSPC-HSPC|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.95e-05 | 181 | 47 | 4 | 54a19cf6a3b752e2391feb8b316bebee0e602d17 | |
| ToppCell | PBMC-Mild-Hematopoietic-HSPC|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.95e-05 | 181 | 47 | 4 | 5b84625b1d3737708001b64f6da9360330d39a27 | |
| ToppCell | PBMC-Mild-Hematopoietic-HSPC-HSPC-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.95e-05 | 181 | 47 | 4 | e7f7b519c2a01c15f26df11ec9b434c0d1630c7a | |
| ToppCell | E18.5-samps-Mesenchymal-Matrix_fibroblast|E18.5-samps / Age Group, Lineage, Cell class and subclass | 4.03e-05 | 182 | 47 | 4 | ceb37c214662a48efb56ab0d015977c6fab478b0 | |
| ToppCell | Control-Hematopoietic_SC-HSPC|Control / Disease group, lineage and cell class | 4.03e-05 | 182 | 47 | 4 | 14e347c0e6444410f1948851407bb18c706569f4 | |
| ToppCell | Control-Hematopoietic_SC|Control / Disease group, lineage and cell class | 4.03e-05 | 182 | 47 | 4 | 43243c6bae2ac7fa3fd1f193a17f61ee4d938ea9 | |
| ToppCell | PBMC-Control-Hematopoietic-HSPC-HSPC|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.03e-05 | 182 | 47 | 4 | d0ebf2f0d5370458ab81485a0017c311077133d5 | |
| ToppCell | PBMC-Control-Hematopoietic-HSPC|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.03e-05 | 182 | 47 | 4 | 918286422b3eab32d962b49aa07b1b9512e51d9d | |
| ToppCell | PBMC-Control-Hematopoietic-HSPC-HSPC-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.03e-05 | 182 | 47 | 4 | 2a6d1246bfb5899a0861c7f2f8fb9b43b0df8acc | |
| ToppCell | COVID-19_Moderate-HSPC|COVID-19_Moderate / disease group, cell group and cell class | 4.30e-05 | 185 | 47 | 4 | cacc6ab5f26f6c803894567fb838ea06eaa7efe5 | |
| ToppCell | hematopoetic_progenitors-CD34+_HSC|World / Lineage and Cell class | 4.67e-05 | 189 | 47 | 4 | 51ff31c9cf5eff98ad01c0455dc4ae4908713575 | |
| ToppCell | Healthy-HSPC|Healthy / disease group, cell group and cell class | 4.67e-05 | 189 | 47 | 4 | 214b225effc40ca1b83dd8052f2a7b80b65d4938 | |
| ToppCell | facs-GAT-Fat-3m|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.77e-05 | 190 | 47 | 4 | 1d92be1b41cff59e834a9d28868f554bd1f3e471 | |
| ToppCell | 10x3'2.3-week_17-19-Hematopoietic-MK-early_MK|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 4.87e-05 | 191 | 47 | 4 | 3839bf57419d3ec3d4464277bb33301d2b7d701f | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.97e-05 | 192 | 47 | 4 | de9c1536d5aee86f9c62acbc54ca8fa581c00f17 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.97e-05 | 192 | 47 | 4 | 25492568f9cbe097b7bb1db50d8b817c80ea87d7 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.27e-05 | 195 | 47 | 4 | 3a0cad69cfc150a27a0666f612f5294c817197d7 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar-AT1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.27e-05 | 195 | 47 | 4 | a71ba5e4043e2d35a45a2c60a96b087e31832345 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.27e-05 | 195 | 47 | 4 | 2b8ee7990267bb52b7e6ae03f509ffebf8908122 | |
| Disease | pulmonary emphysema (biomarker_via_orthology) | 3.25e-05 | 6 | 44 | 2 | DOID:9675 (biomarker_via_orthology) | |
| Disease | keratoconus (is_marker_for) | 4.54e-05 | 7 | 44 | 2 | DOID:10126 (is_marker_for) | |
| Disease | Adenocarcinoma Of Esophagus | 1.96e-04 | 14 | 44 | 2 | C0279628 | |
| Disease | obesity (implicated_via_orthology) | 2.96e-04 | 215 | 44 | 4 | DOID:9970 (implicated_via_orthology) | |
| Disease | eye colour measurement | 3.12e-04 | 218 | 44 | 4 | EFO_0009764 | |
| Disease | Nasopharyngeal carcinoma | 4.93e-04 | 22 | 44 | 2 | C2931822 | |
| Disease | insomnia measurement | 5.00e-04 | 443 | 44 | 5 | EFO_0007876 | |
| Disease | retinitis pigmentosa (implicated_via_orthology) | 7.45e-04 | 27 | 44 | 2 | DOID:10584 (implicated_via_orthology) | |
| Disease | colorectal cancer (is_implicated_in) | 7.88e-04 | 121 | 44 | 3 | DOID:9256 (is_implicated_in) | |
| Disease | attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement | 1.15e-03 | 801 | 44 | 6 | EFO_0003888, EFO_0007052, MONDO_0002491 | |
| Disease | acute lymphoblastic leukemia (is_marker_for) | 1.18e-03 | 34 | 44 | 2 | DOID:9952 (is_marker_for) | |
| Disease | lymphocyte count | 1.29e-03 | 1464 | 44 | 8 | EFO_0004587 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| MPPPADIVKVAIEWP | 1 | Q92556 | |
| DLDGDWPAPMLQKPP | 246 | Q96L12 | |
| MEPEDLPWPGELEEE | 1 | Q8TCU4 | |
| PDVEVQGPDWHLKMP | 1241 | Q09666 | |
| PDVDVHGPDWNLKMP | 3461 | Q09666 | |
| PDVDVQGPDWHLKMP | 3791 | Q09666 | |
| GKKPELTLVWEPEDM | 811 | Q8IYB7 | |
| IKAWPPAGMTIPEED | 286 | Q9HBZ2 | |
| DKPMGPLLVATFWPE | 501 | P08253 | |
| KPSMLEDPWAGLEPV | 141 | Q8TAP9 | |
| EEGIKMSKPKWPPED | 546 | Q9UHB6 | |
| LDPGPAKEEWNMDPL | 306 | P0C025 | |
| VPLPLVSWMKDGEPL | 3441 | Q8NDA2 | |
| EDGQPMVLKLKDWPP | 1476 | Q7LBC6 | |
| WKEPVSPMELTGPED | 561 | O94953 | |
| PEKGMPPDELSGWDK | 746 | Q13237 | |
| LVKDWPPIKPEQAME | 586 | P42336 | |
| NPDKAVPIPEKMSEW | 41 | Q9H875 | |
| VALGVPKPEITWEMP | 2551 | Q6WRI0 | |
| NEKEPMVLKLKDWPP | 1036 | Q9Y4C1 | |
| SPSEKLEPWDPGMRK | 66 | Q53S99 | |
| LSPEVPLPGMKWVDN | 701 | Q96N67 | |
| MPPPSDIVKVAIEWP | 1 | Q96JJ3 | |
| TADEWAEKMPKGPPP | 1141 | Q5THR3 | |
| LQKVPPEWKALTDMP | 241 | P02671 | |
| WEAGAVPAPKVPIKM | 16 | Q96NZ9 | |
| EDVPWDKMLPPKLVP | 246 | A4D263 | |
| ACIEIKWMPPEKPNG | 3881 | O75445 | |
| PDVKPWLAGPKEEDM | 196 | P05423 | |
| WLAGPKEEDMEVDIP | 201 | P05423 | |
| EPPKSPEKMWPKDEN | 236 | Q96KN7 | |
| EPPVPPMDWEALEKH | 216 | P0DPB3 | |
| DVCEKWGEMPPLQPK | 171 | Q15544 | |
| PLEWALGVMPKPDPT | 401 | Q8IV61 | |
| EEPPVPPMDWEALEK | 291 | B3KU38 | |
| PKIMDVGWPELHAPP | 66 | Q68CZ2 | |
| PGDAWKMALPAEPDP | 846 | Q9NRC6 | |
| EPMGLLWALEPEKPF | 76 | Q8N9L9 | |
| PEMPLAWKEINDGKE | 316 | A8MXE2 | |
| WPPTKMGLDEDNEPD | 291 | O00327 | |
| PDWEEAVKMPVGILP | 261 | Q9NRA0 | |
| LKMREDWGVSPDPPT | 536 | Q96MS0 | |
| APGFKWKPAELEPME | 156 | Q92670 | |
| PKPEVVMLEQGKEPW | 71 | Q52M93 | |
| MWPSVPDEKGELLNP | 441 | O00329 | |
| VELDCWKGKPPDEEP | 356 | Q00722 | |
| PPTPKEQKDWFIEMP | 256 | P11137 | |
| PIPEKKWFMEPAVIV | 436 | Q9HD45 | |
| KWPKVEDPMPESKVG | 26 | Q8NB50 | |
| IDVDWSGLMPKHPKE | 1496 | Q5T200 | |
| EMTWMDVPGDKLLEP | 386 | Q9UN37 | |
| IMDDDDVPSWPPTKL | 31 | Q6DD87 | |
| KEQPWGEMKEPPWDP | 776 | Q8N5Q1 |